| Serial Number | 90011832 |
| Word Mark | INTELLISEP |
| Filing Date | Friday, June 19, 2020 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Friday, June 9, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 26, 2021 |
| Goods and Services | medical services; medical treatment of sepsis, cancer and immune-mediated diseases; medical analysis services in the fields of cytometry, oncology, and hematology |
| Goods and Services | medical diagnostic apparatus for analysis of biomarker levels and/or relative expression of host response genes, medical diagnostic apparatus for analyzing gene expression tests using bioinformatics and machine learning algorithms, medical diagnostic apparatus for analyzing gene expression tests, gene expression profiling assays, genetic information, protein biomarkers, clinical data and/or demographic information to aid treatment decisions; sample preparation devices for medical diagnostic purposes in the nature of lysing apparatus in the nature of bd lyse wash assistant, coulter qprep, and related recorded data management software sold as a unit; diagnostic test apparatus for medical use for analysis of gene expression, protein expression, metabolite expression, inflammation, immune- suppression, immune disorders; medical and medical diagnostic apparatus for use in analysis of gene expression tests, analysis of gene expression profiling assays, analyzing genetic information, analyzing and detecting protein biomarkers, analyzing clinical data, and/or analyzing demographic information; point of care medical devices, namely, polymerase chain reaction (pcr) testing equipment for analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders; medical devices for use in the treatment of sepsis, cancer and other immune-mediated conditions in the fields of oncology, hematology, and for diagnosis and treatment of sepsis; medical testing kits comprising apparatus for taking blood, apparatus for blood analysis, test tubes, and cartridges for cancer and other immune-mediated conditions; apparatus for diagnostic purposes, namely, medical diagnostic apparatus for testing for cancer and other immune-mediated conditions in the fields of oncology and hematology; automated medical instruments, namely, host-response testing equipment, cytometers which use electronics and optical fluorescence flow cytometry to analyze human cells; ultraviolet visible and near infrared fluorescence analyzers for medical use and components therefor; imaging platforms, namely, medical imaging apparatus for imaging and analysis of cells and cell organelles, molecular diagnostics and imaging cytometry for medical use; medical micro imaging apparatuses for imaging and analysis of bacteriums, viruses, cells and cell organelles for medical use and components therefor; medical micro imaging apparatuses for molecular diagnostics and cytometry for medical diagnostic use and components therefor; medical apparatuses for the examination and analysis of proteins, peptides, antibodies and molecules for medical diagnostic use and components therefor; digital imaging platforms, namely, medical micro imaging apparatus for acquiring and processing microscopic images for medical diagnostic use; digital imaging platforms, namely, medical micro imaging apparatus for use in the examination of cells, proteins and peptides for medical diagnostic use; diagnostic apparatus for medical use, namely, computed tomography scanners, fluorescent microscope systems comprised of optical detection modalities, apparatus in the nature of apparatus for performing complete blood count measurements and measurements of monocyte distribution with magnification objective for use in performing fluorescent antibody technique analysis and fluorescent protein technique analysis; diagnostic apparatus for medical use, namely, automatic cell sorting systems comprised of apparatus for performing single-cell analysis, optical detection modalities apparatus in the nature of optical measurement equipment, electrical detection modalities apparatus for medical diagnostic purposes, mechanical detection modalities apparatus for determining lateral displacement for medical diagnostic purposes; flow cytometers for use in flow cytometry analysis and in fluorescence activated cell sorting for medical diagnostic purposes; flow cytometers |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 17, 2020 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 17, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Cytovale Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Francisco, CA 94134 |
| Party Name | Cytovale Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Francisco, CA 94134 |
| Event Date | Event Description |
| Saturday, June 10, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, June 9, 2023 | SOU EXTENSION 3 GRANTED |
| Thursday, June 8, 2023 | SOU EXTENSION 3 FILED |
| Thursday, June 8, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, January 17, 2023 | ASSIGNED TO EXAMINER |
| Thursday, December 15, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, December 14, 2022 | SOU EXTENSION 2 GRANTED |
| Monday, December 12, 2022 | SOU EXTENSION 2 FILED |
| Monday, December 12, 2022 | SOU TEAS EXTENSION RECEIVED |
| Friday, May 20, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, May 19, 2022 | SOU EXTENSION 1 GRANTED |
| Monday, May 9, 2022 | SOU EXTENSION 1 FILED |
| Thursday, May 19, 2022 | DIVISIONAL PROCESSING COMPLETE |
| Monday, May 2, 2022 | DIVISIONAL REQUEST RECEIVED |
| Monday, May 2, 2022 | TEAS REQUEST TO DIVIDE RECEIVED |
| Saturday, May 14, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, May 9, 2022 | SOU TEAS EXTENSION RECEIVED |
| Monday, May 2, 2022 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, December 21, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, October 26, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 26, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 6, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 21, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, September 21, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, September 21, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, September 21, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, September 21, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, March 29, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 29, 2021 | NON-FINAL ACTION E-MAILED |
| Monday, March 29, 2021 | NON-FINAL ACTION WRITTEN |
| Tuesday, February 23, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, February 23, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, February 22, 2021 | ASSIGNED TO LIE |
| Wednesday, November 18, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, September 15, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, September 15, 2020 | NON-FINAL ACTION E-MAILED |
| Tuesday, September 15, 2020 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 9, 2020 | ASSIGNED TO EXAMINER |
| Friday, July 17, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, June 23, 2020 | NEW APPLICATION ENTERED |